Seeking Alpha

KBIO
KaloBios Pharmaceuticals - NASDAQ

4/18/2014, 4:57 PM ET
Quote & Analysis Breaking News StockTalk
kbio chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There are 2 articles on this stock available only to PRO subscribers.
Other Articles
There are no Transcripts on KBIO.
OTHER NEWS
KBIO vs. ETF Alternatives
Company Description

KaloBios Pharmaceuticals Inc is a biopharmaceutical company focused on the development of monoclonal antibody therapeutics for diseases that represent a significant burden to society and to patients and their families.

OTHER NEWS